<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04708769</url>
  </required_header>
  <id_info>
    <org_study_id>STU00212742</org_study_id>
    <nct_id>NCT04708769</nct_id>
  </id_info>
  <brief_title>Elements Vital to Treat Obesity Study</brief_title>
  <acronym>EVO</acronym>
  <official_title>Evaluating the EVO Treatment Optimized for Resource Constraints: Elements Vital to Treat Obesity.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objective of this study is to evaluate the first rigorously optimized, remotely&#xD;
      delivered treatment for obesity against the current gold standard treatment in a head-to-head&#xD;
      randomized controlled trial. The investigators will be comparing the previously developed and&#xD;
      optimized behavioral weight loss intervention (APP) to the Diabetes Prevention Program (DPP),&#xD;
      to evaluate program weight-loss success and cost-effectiveness.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The proposed study seeks to determine if the APP program is an effective, resource-sensitive&#xD;
      strategy to manage weight for obesity, as compared to the DPP program. During the 24-week&#xD;
      active intervention phase, participants will be randomized to one of two treatments: 1) APP,&#xD;
      wherein participants receive calorie, fat, and physical activity goals via a Smartphone&#xD;
      application for self-monitoring, online educational readings, and biweekly sessions with a&#xD;
      Health Promotionist; or 2) DPP, wherein participants are guided to self-monitor their&#xD;
      physical activity, food intake, and weight via a participant log, and are guided through 16&#xD;
      sessions by a Health Promotionist. Assessments to track progress will occur remotely at the&#xD;
      3-month, 6-month, and 12-month time points of the program.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 16, 2021</start_date>
  <completion_date type="Anticipated">June 2025</completion_date>
  <primary_completion_date type="Anticipated">June 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight</measure>
    <time_frame>Baseline to 6-Months</time_frame>
    <description>Participant change in weight, in kilograms, from baseline to 6-months.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Costs of treatment</measure>
    <time_frame>12 Months</time_frame>
    <description>Costs of EVO versus DPP implementation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">524</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Smartphone App Participants (APP)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Smartphone application, diet and activity goals, online lessons, brief remote sessions with a Health Promotionist</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diabetes Prevention Program Participants (DPP)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participant program manual, diet and activity logs, hour long remote sessions with a Health Promotionist</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Smartphone App Participants (APP)</intervention_name>
    <description>Participants will receive calorie, fat, and physical activity goals, a Smartphone application for self-monitoring their diet, activity and weight, online educational readings, and brief bi-weekly remote health sessions with a Health Promotionist. They will also be provided with a wireless bluetooth scale and portable blood pressure machine.</description>
    <arm_group_label>Smartphone App Participants (APP)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Diabetes Prevention Program Participants (DPP)</intervention_name>
    <description>In accordance with the Center for Disease Control curriculum, participants will receive a participant log for tracking physical activity, food intake, and weight, a paper participant guide with worksheets, logs, and psycho-educational materials, and 16 hour long remote sessions with a Health Promotionist. They will also be provided with a wireless bluetooth scale and portable blood pressure machine.</description>
    <arm_group_label>Diabetes Prevention Program Participants (DPP)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  BMI 30-45&#xD;
&#xD;
          -  Weight stable&#xD;
&#xD;
          -  Own a Smartphone and be willing to install our Smartphone app&#xD;
&#xD;
          -  Willing to conduct video conference calls with study staff&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Enrolled in any formal weight loss program&#xD;
&#xD;
          -  Taking anti-obesity medications&#xD;
&#xD;
          -  Not taking medications that may cause weight gain&#xD;
&#xD;
          -  Unstable medical conditions&#xD;
&#xD;
          -  Diabetes requiring insulin supplementation&#xD;
&#xD;
          -  Crohn's Disease&#xD;
&#xD;
          -  Diagnosis of obstructive sleep apnea requiring intervention (i.e., CPAP)&#xD;
&#xD;
          -  Assistive devices for mobility&#xD;
&#xD;
          -  Hospitalizations for a psychiatric disorder within the past 5 years&#xD;
&#xD;
          -  Cardiovascular disease symptoms while performing moderate intensity exercise&#xD;
&#xD;
          -  Pregnancy, trying to get pregnant, or lactating.&#xD;
&#xD;
          -  Bulimia or binge eating disorder&#xD;
&#xD;
          -  Reports of active suicidal ideation&#xD;
&#xD;
          -  Current substance abuse or dependence besides nicotine dependence&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Angela Pfammatter, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laura Scanlan, MS</last_name>
    <phone>312-503-1395</phone>
    <email>laura.scanlan@northwestern.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Scanlan, MS</last_name>
      <phone>312-503-1395</phone>
      <email>laura.scanlan@northwestern.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>January 12, 2021</study_first_submitted>
  <study_first_submitted_qc>January 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 14, 2021</study_first_posted>
  <last_update_submitted>April 12, 2021</last_update_submitted>
  <last_update_submitted_qc>April 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Angela Fidler Pfammatter, PhD</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Weight Loss</keyword>
  <keyword>Diet</keyword>
  <keyword>Physical Activity</keyword>
  <keyword>Self Monitoring</keyword>
  <keyword>Mobile Health</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

